|
|
N/A
NC3845711175333-50-2
-
|
|
|
|
|
N/A
NC3845701175333-51-3
-
|
|
|
|
|
|
|
|
|
|
N/A
NC3845681175333-59-1
-
|
|
|
|
|
N/A
NC3845671175333-60-4
-
|
|
|
|
|
N/A
NC3845661175333-89-7
-
|
|
|
|
|
N/A
NC3845651175333-90-0
-
|
|
|
|
|
N/A
NC3845641175333-91-1
-
|
|
|
|
|
N/A
NC3845631175333-92-2
-
|
|
|
|
|
N/A
NC3845621175333-93-3
-
|
|
|
|
|
|
|
|
|
|
N/A
NC3845601175334-01-6
-
|
|
|
|
|
N/A
NC3845591175334-02-7
-
|
|
|
|
|
N/A
NC3845581175334-03-8
-
|
|
|
|
|
Ethanimidic acid, 2,2,2-trichloro-, (2R,3R,3aS,10aR)-8-[(E)-[(dimethylamino)methylene]amino]-2,3,3a,6,7,10a-hexahydro-2-[[(4-methoxyphenyl)diphenylmethoxy]methyl]-6-oxofuro[2′′,3′′:4′,5′]thiazolo[3′,2′:1,2]imidazo[4,5-c]pyridin-3-yl ester
NC3845571175359-39-3
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 2,3-dihydro-3-(hydroxymethyl)-8-(phenylmethyl)-, [2R-(2α,3β,5α)]-
NC384554117538-42-8
-
|
|
|
|
|
2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 2,3-dihydro-3-(hydroxymethyl)-8-[[3-(phenylmethoxy)phenyl]methyl]-, [2R-(2α,3β,5α)]-
NC384553117538-43-9
-
|
|
|
|
|
N/A
NC3845521175394-25-8
-
|
|
|